First Lutein Based Eyedrop (Internationally Patented)

>  Worldwide patent held by OMISAN, making us the only company to successfully formulateLutein into a stable, effective eyedrop. This breakthrough delivers the powerful antioxidant carotenoid locally, something previously only achievable through hard food supplements.

> Lutein: Delivers targeted antioxidant and contributes to blue-light filtering properties to help protect the macula and retina from oxidative stress.

> CMC (Carboxymethylcellulose): Provides superior, long-lasting lubrication and tearfilm stabilization, crucial for patient comfort and epithelial healing.

> Strategic Post-Operative Care: Suitable for use in post-operative regimens. Its specialized preservative system is designed to contribute to maintaining the ocularsurface integrity after surgery by ensuring the environment is well-lubricated and protected, working in conjunction with (not replacing) your prescribed antibiotics and standard care protocols.